Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (13195)	8/13/1998 11:19:00 AM
From: DaiS	Respond to of 23519

Riskman said he was told that sales in Sweden started last week. I was told by Mikael Widell at Astra that muse was launched in Sweden on 1 July. Earlier I was told by someone else at Astra that it was introduced in June. I think introduced/launched/sales can mean different things. I am still awaiting information from Astra.

To: Mkilloran who wrote (13195)	8/13/1998 11:36:00 AM
From: DaiS	Read Replies (3) \| Respond to of 23519

FWIW, wizkidaces on yahoo, with an ID update of 12 August, claimed that the big news by end of August related to gene therapy announcement by Vivus - re experiments on rats. In fact he appeared not to understand too well about either gene therapy or muse and was corrected by another poster. The information that I gave earlier on gene therapy was obtained from a still unpublished manuscript by Dr Christ. This was a photocopy of page proofs. Since interval between receipt by authors of page proofs and publications is usually short, 1-3 months, the paper itself could be coming out this or next month. It will be in one of the journals of the American Physiological Society, don't know which one. No!! here is the abstract, oac3.hsc.uth.tmc.edu And the July issue of the journal oac3.hsc.uth.tmc.edu It must in August!? So is Vivus going to make a splash with this. Remember how much that rat cancer cure made entremed go up. Remember that here though, it is human cDNA that is used. If human DNA works in rats it will certainly be expected to work in humans.

To: Mkilloran who wrote (13195)	8/13/1998 11:47:00 AM
From: DaiS	Respond to of 23519

For EU Viagra Users From: McFadden Theresa <Theresa.McFadden@emea.eudra.org> To: Copies to: Bass Rolf <Rolf.Bass@emea.eudra.org>, Heng Leng <Leng.Heng@emea.eudra.org> Date sent: Thu, 13 Aug 1998 15:06:13 +0100 VIAGRA Dear , In response to your e-mail to Prof. Bass of 6 August 1998 regarding Viagra (sildenafil), the cautions against driving or operating machinery in the draft package insert for Viagra are included in order to take into account several side effects (dizziness and abnormal vision) that could have an impact on such activities. With regard to your request for documentary evidence relating to the effect of sildenafil on retinal function, the EMEA can not provide you with the documentation submitted as part of the application for marketing authorisation for sildenafil as this is proprietary information which is confidential. However, a summary of this information will be available in the European Public Assessment Report (EPAR) which will be made public shortly after the product is authorised in the EU: Yours sincerely, Dr Patrick Le Courtois Head of Sector New Chemical Substances CC. Rolf Bass Leng Heng